Overview
The HYUMC registry is a two-center, real-world registry of percutaneous coronary intervention in patients with coronary artery disease. From January 2012, PCI-treated patients from Hanyang University Seoul Hospitals and Hanyang University Guri Hospitals were enrolled in this registry.
The aim of this registry is to examine the long-term clinical outcomes and identify predictors of adverse outcomes following percutaneous coronary intervention conducted at academic hospitals.
Description
In the HYUMC registry, the researchers have gathered and assessed various demographic, laboratory, echocardiographic, and angiographic measurements (both on-admission and during follow-up), as well as conducted questionnaires among patients who underwent percutaneous coronary intervention. The primary focus of this registry is to examine the effects of these parameters on long-term clinical outcomes.
Eligibility
Inclusion Criteria:
Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with
from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang
University Guri Hospital, Korea.
Exclusion Criteria:
- second or subsequent hospitalization records of patients with multiple admissions
- patients who died during index hospitalization
- patients who treated with first-generation drug eluting stent
- patients with an outpatient follow-up record of less than 6 months
- patients with insufficient medical records.